Experienced in Kaposi Sarcoma

Dr. Auris Huen

Dermatology
UT MD Anderson Cancer Center
210 Ashville Ave # 408, 
Cary, NC 
Offers Telehealth
Experienced in Kaposi Sarcoma
UT MD Anderson Cancer Center
210 Ashville Ave # 408, 
Cary, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Auris Huen is a Dermatologist in Cary, North Carolina. Dr. Huen is rated as an Experienced provider by MediFind in the treatment of Kaposi Sarcoma. Her top areas of expertise are Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Lymphomatoid Papulosis, and Thymectomy.

Her clinical research consists of co-authoring 57 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Kaposi Sarcoma.

Specialties
Dermatology
Licenses
Dermatology in TX
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

UT MD Anderson Cancer Center
210 Ashville Ave # 408, Cary, NC 27518
Call: 713-792-6161

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase II Trial of Brentuximab Vedotin (SGN-35) at Dose of 1.8 mg/kg IV Every 3 Weeks in Patients With CD30-positive Lymphoproliferative Disorders (Cutaneous Anaplastic Large T-cell Lymphoma (ALCL), Mycosis Fungoides, and Extensive Lymphomatoid Papulosis (LyP)
Phase II Trial of Brentuximab Vedotin (SGN-35) at Dose of 1.8 mg/kg IV Every 3 Weeks in Patients With CD30-positive Lymphoproliferative Disorders (Cutaneous Anaplastic Large T-cell Lymphoma (ALCL), Mycosis Fungoides, and Extensive Lymphomatoid Papulosis (LyP)
Enrollment Status: Active_not_recruiting
Publish Date: January 20, 2026
Intervention Type: Drug
Study Drug: SGN-35
Study Phase: Phase 2
A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects With Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors
A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects With Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors
Enrollment Status: Terminated
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drugs: TTI-621, Rituximab
Study Phase: Phase 1
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
Enrollment Status: Terminated
Publish Date: October 28, 2022
Intervention Type: Drug
Study Drug: Naloxone Hydrochloride Lotion
Study Phase: Phase 3
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase I/Ib, Dose Escalation Study to Evaluate Safety and Efficacy of RP6530, a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed or Refractory T-cell Lymphoma
A Phase I/Ib, Dose Escalation Study to Evaluate Safety and Efficacy of RP6530, a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed or Refractory T-cell Lymphoma
Enrollment Status: Completed
Publish Date: January 13, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 4 Less Clinical Trials

56 Total Publications

Primary cutaneous anaplastic large cell lymphoma: Clinical response with low dose brentuximab vedotin on a patient receiving hemodialysis.
Primary cutaneous anaplastic large cell lymphoma: Clinical response with low dose brentuximab vedotin on a patient receiving hemodialysis.
Journal: JAAD case reports
Published: July 31, 2025
View All 56 Publications
Similar Doctors
Experienced in Kaposi Sarcoma
Dr. Mika Tabata
Dermatology
Experienced in Kaposi Sarcoma
Dr. Mika Tabata
Dermatology

UT MD Anderson Cancer Center

210 Ashville Ave # 408, 
Cary, NC 
 (1050.9 miles away)
713-792-6161
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mika Tabata is a Dermatologist in Cary, North Carolina. Dr. Tabata is rated as an Experienced provider by MediFind in the treatment of Kaposi Sarcoma. Her top areas of expertise are Hypersensitivity Vasculitis, Granuloma Annulare, Dermatomyositis, and Perniosis.

Experienced in Kaposi Sarcoma
Dr. Melodi Whitley
Dermatology
Experienced in Kaposi Sarcoma
Dr. Melodi Whitley
Dermatology

Duke University Medical Center

5324 McFarland Rd, 
Durham, NC 
 (1044.3 miles away)
919-401-3376
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Melodi Whitley is a Dermatologist in Durham, North Carolina. Dr. Whitley is rated as an Experienced provider by MediFind in the treatment of Kaposi Sarcoma. Her top areas of expertise are Pyoderma Gangrenosum, Melanoma, Actinic Keratosis, Warts, and Tissue Biopsy.

Priyadharsini Nagarajan
Experienced in Kaposi Sarcoma
Dr. Priyadharsini Nagarajan
Dermatology
Experienced in Kaposi Sarcoma
Dr. Priyadharsini Nagarajan
Dermatology

UT MD Anderson Cancer Center

210 Ashville Ave # 408, 
Cary, NC 
 (1050.9 miles away)
713-792-6161
Languages Spoken:
English
See accepted insurances

Priyadharsini Nagarajan is a Dermatologist in Cary, North Carolina. Dr. Nagarajan is rated as a Distinguished provider by MediFind in the treatment of Kaposi Sarcoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Extramammary Paget Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

VIEW MORE KAPOSI SARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Huen's expertise for a condition
ConditionClose
  • Elite
  • Cutaneous T-Cell Lymphoma (CTCL)
    Dr. Huen is
    Elite
    . Learn about Cutaneous T-Cell Lymphoma (CTCL).
    See more Cutaneous T-Cell Lymphoma (CTCL) experts
  • Lymphomatoid Papulosis
    Dr. Huen is
    Elite
    . Learn about Lymphomatoid Papulosis.
    See more Lymphomatoid Papulosis experts
  • Mycosis Fungoides
    Dr. Huen is
    Elite
    . Learn about Mycosis Fungoides.
    See more Mycosis Fungoides experts
  • Sezary Syndrome
    Dr. Huen is
    Elite
    . Learn about Sezary Syndrome.
    See more Sezary Syndrome experts
  • T-Cell Lymphoma
    Dr. Huen is
    Elite
    . Learn about T-Cell Lymphoma.
    See more T-Cell Lymphoma experts
  • Distinguished
  • Anaplastic Large Cell Lymphoma
    Dr. Huen is
    Distinguished
    . Learn about Anaplastic Large Cell Lymphoma.
    See more Anaplastic Large Cell Lymphoma experts
  • Lymphocytic Infiltrate of Jessner
    Dr. Huen is
    Distinguished
    . Learn about Lymphocytic Infiltrate of Jessner.
    See more Lymphocytic Infiltrate of Jessner experts
  • Advanced
  • Actinic Keratosis
    Dr. Huen is
    Advanced
    . Learn about Actinic Keratosis.
    See more Actinic Keratosis experts
  • Bullous Pemphigoid
    Dr. Huen is
    Advanced
    . Learn about Bullous Pemphigoid.
    See more Bullous Pemphigoid experts
  • Experienced
  • Acrogeria, Gottron Type
    Dr. Huen is
    Experienced
    . Learn about Acrogeria, Gottron Type.
    See more Acrogeria, Gottron Type experts
  • ADULT Syndrome
    Dr. Huen is
    Experienced
    . Learn about ADULT Syndrome.
    See more ADULT Syndrome experts
  • Basal Cell Skin Cancer
    Dr. Huen is
    Experienced
    . Learn about Basal Cell Skin Cancer.
    See more Basal Cell Skin Cancer experts
  • Bazex Syndrome
    Dr. Huen is
    Experienced
    . Learn about Bazex Syndrome.
    See more Bazex Syndrome experts
  • Bowen's Disease
    Dr. Huen is
    Experienced
    . Learn about Bowen's Disease.
    See more Bowen's Disease experts
  • Chronic T-Cell Leukemia (CTCL)
    Dr. Huen is
    Experienced
    . Learn about Chronic T-Cell Leukemia (CTCL).
    See more Chronic T-Cell Leukemia (CTCL) experts
View All 49 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.